Pulmonary Function and Neuromuscular Disease

This study aims to describe the evolution of pulmonary function in 3 neuromuscular diseases : Duchenne muscular dystrophy, Werdnig-Hoffinann disease, congenital myopathy, monitored in Besançon university hospital.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuromuscular Diseases Nervous System Diseases

Age range

6 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Besançon

Besançon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Neuromuscular disease
Followed-up in Besançon University Hospital
With at least 2 Pulmonary Function Tests previously performed

Exclusion criteria

Mental deficiency
Facial expressions disorders

Treatment and study plan

Primary outcomes

FVC (Forced Vital Capacity)

Time frame: Year 12

Percentage of decrease of FVC sitting or lying down

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: PREMDEN

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Feb 26, 2018
Registry last updated: Aug 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed